Literature DB >> 24843089

The Role of Leg Compression in the Treatment of Deep Vein Thrombosis.

Hugo Partsch1.   

Abstract

Up until today mobile outpatients are put into bed as soon as the diagnosis of deep vein thrombosis (DVT) is made. Fear of pulmonary embolism (PE) is the main rationale for bed-rest; additional arguments are pain and swelling which are expected to resolve faster during leg elevation. Based on previous work it is demonstrated that keeping mobile patients with acute DVT walking under exact anticoagulation does not increase the risk for symptomatic PE in comparison with bed-rest and that there is an immediate reduction of pain and swelling when good compression is applied and the patient is encouraged to walk. Immediate compression and walking seems also to reduce the incidence of a postthrombotic syndrome. One presumed mechanism of action of this adjunct treatment modality is the increase of shear stress in the microcirculation of the vein wall releasing anti-inflammatory and anti-coagulatory mediators.
© The Author(s) 2014 Reprints and permissions: sagepub.co.uk/journalsPermissions.nav.

Entities:  

Keywords:  Deep vein thrombosis; compression therapy; postthrombotic syndrome; pulmonary embolism

Year:  2014        PMID: 24843089     DOI: 10.1177/0268355514528128

Source DB:  PubMed          Journal:  Phlebology        ISSN: 0268-3555            Impact factor:   1.740


  3 in total

Review 1.  [Innovations in medical compression therapy].

Authors:  H Riebe; W Konschake; T Westphal; M Jünger
Journal:  Hautarzt       Date:  2020-01       Impact factor: 0.751

2.  Pulmonary Thromboembolism Caused by Prolonged Compression at the Femoral Access Site and a Venous Aneurysm of the Ipsilateral Popliteal Vein.

Authors:  Kentaro Arakawa; Hideo Himeno; Jin Kirigaya; Fumie Otomo; Hidefumi Nakahashi; Satoru Shimizu; Mitsuaki Endo; Kazuo Kimura; Satoshi Umemura
Journal:  Ann Vasc Dis       Date:  2016-02-12

3.  Risks and contraindications of medical compression treatment - A critical reappraisal. An international consensus statement.

Authors:  Eberhard Rabe; Hugo Partsch; Nick Morrison; Mark H Meissner; Giovanni Mosti; Christopher R Lattimer; Patrick H Carpentier; Sylvain Gaillard; Michael Jünger; Tomasz Urbanek; Juerg Hafner; Malay Patel; Stephanie Wu; Joseph Caprini; Fedor Lurie; Tobias Hirsch
Journal:  Phlebology       Date:  2020-03-02       Impact factor: 1.740

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.